chrisvoncsefalvay/vaers-outcomes huggingface dataset:
MINIMAL DISCOMFORT AT THE INJECTION LOCATION; TIREDNESS; HEADACHE; SORE TO THE TOUCH ONLY; This spontaneous report received from a patient concerned a 73 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetes, and other pre-existing medical conditions included the patient has blood type of a (RH negative).The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on right arm on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced minimal discomfort at the injection location. On 21-MAR-2021, the subject experienced tiredness. On 21-MAR-2021, the subject experienced headache. On 21-MAR-2021, the subject experienced sore to the touch only. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from minimal discomfort at the injection location, tiredness, headache, and sore to the touch only. This report was non-serious.
Went to bed at night at 11:00pm. Woke up at 1am covered in red blotchy rash in face, neck, arm took BENADRYL. Woke up a bit later and it had spread to knees and legs. Next day was hoarse, nausea, ears were itchy. Went to ER on 10/17/13 because felt like throat closing up. Was given BENADRYL IV, antihistamine blocker, nausea. Was in ER of 2 1/2 hours and released afterwards. Site of injection was red area the size of 1/2 dollar the day after the vaccination. The arm was swollen and sore; couldn't sleep because it was so swollen. Followed up with doctor on 10/21. Today feel OK, injection site is size of dime.
worst cold; Initial information received on 17-Nov-2020 regarding an unsolicited valid non-serious case received from a social media consumer (patient).  This case involves patient (unknown demographics) who experienced worst cold (nasopharyngitis), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious worst cold (nasopharyngitis), two weeks following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was not reported.  There will be no information available on the batch number for this case.
No other adverse events reported; an expired dose of ROTATEQ was administered to a patient today; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.     On 23-MAR-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) 1 dose, lot number 1707470, expiration date 21-MAR-2022 (route of administration not reported) for prophylaxis (expired product administered). No adverse event was reported.
her left, upper arm became bruised and sore; her left, upper arm became bruised and sore/muscle soreness, like from a flu shot; half of the vaccine came out at the injection site and she did not receive the full dose.; This is a spontaneous report from a Pfizer from a contactable nurse reporting for self. This 42-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249, expiry date: 31May2021) via unspecified route of administration on 06Jan2021 at single dose in left upper arm for COVID-19 immunisation. Medical history and concomitant medications were none. The patient previously received her first dose of BNT162B2 (Lot Number: EJ1685) on 18Dec2020 IM in her right deltoid muscle at single dose for COVID-19 immunisation at age of 42-year-old. She said when she received her first dose, the person who administered the shot used a 3-finger width distance from her right shoulder bone when administering the vaccine into her right deltoid muscle. She said after receiving the first dose, it was about 9 hours later before her right shoulder hurt. The patient received the second dose on 06Jan2021. She said at least half of the vaccine came out of her arm (came out at the injection site), so she did not receive the full second dose.  She said when she received her second dose, the person who administered the vaccine used only a 2- finger width distance from her left shoulder, and administered the vaccine very high up on her left arm. She said her left, upper arm became bruised and sore within an hour after receiving the second dose of vaccine. She said her left arm is still hurting today, clarifying she had a muscle soreness, like from a flu shot. The events did not require a visit to emergency room or physician office. The outcome of events was not recovered. The reporter considered the relatedness of vaccine to all events was related, and considered event her left, upper arm became bruised and sore/ muscle soreness, like from a flu shot as not serious.
I had normal injection site tenderness right after, but within a few hours I could not lift my arm more than 45 degrees. Pain continued to worsen and spread. Now shoots from ear to finger tip.
The next day a rash appeared on my forearms and now is on my ankles, calves and scalp.; Severe headache; chills; flu like symptoms; This is a spontaneous report from a contactable other healthcare professional (patient). A 53-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscularly at left arm on 18Dec2020 at 14:00 at single dose for covid-19 immunization at workplace clinic.  Medical history included hypolipidaemia, allergic to sulfa drugs (hives), allergy to adhesive (severe skin blistering).  There was non other vaccine in four weeks and no other medications in two weeks.  The patient previously took naproxen (NAPROSYN) and amoxicillin clavulanic acid (AUGMENTIN ) and was allergic to both drugs, and experienced anaphylaxis for naproxen.  The patient experienced severe headache, chills and flu like symptoms the night after the shot on 18Dec2020. The next day on 19Dec2020 at 10: 00 AM a rash appeared on her forearms and was on her ankles, calves and scalp at time of the report. No treatment for the events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination,  the patient had not been tested for COVID-19. The outcome of the events was not resolved.
Around 3 weeks after the vax  - a short time after going to bed - I started to get mild, few-minutes-long cramps in one or both lower legs . (I had a history over the past 8 or so years of experiencing foot swelling and neuropathy in both feet. In past few years the neuropathy extended into the lower part of both legs without foot swelling. The neffect was essentially a discomforting numbness. in both feet and lower legs in bed before going to sleep.) In the time since then  -  within a week from the first cramping - the leg cramps became prolonged and the pain excruciating (scale from 1-10 ...10)  There were no leg cramps during the day ( I normall ride a pedal recumbent trike - pulling a trailer carrying about 80
redness; swelling; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness) and SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness) and SWELLING (swelling). At the time of the report, ERYTHEMA (redness) and SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
04/09/21- severe edema especially feet & legs - resolved next day. 04/10/21- joint pain knees & elbows and achiness throughout entire spine - resolved next day. 04/11/21- several watery blisters - left hand, face & right thigh.  04/13/21- SEVERE vertigo lasting several days accompanied with on/off headache. 04/15/21- very emotional still vertigo slight 04/17/21- still slight vertigo on/off. 04/18/21- still slight vertigo. Headache. Depressed. Very foggy and out of it feeling.
Large erythematous, raised patch; very warm to touch and painful. Area progressed to entire size of right upper ant thigh and spread around to partial post thigh.  Pt did not want to bear wt.  Fever to 102f
No additional AEs or PQC.; Improperly stored for VARIVAX, Temperature: 4C, Time frame: 108 Hours; This spontaneous report was received from a medical assistant referring to a 16-month-old patient of unknown gender.  The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not provided.   On 27-JUN-2022, the patient was vaccinated with one dose of an improperly stored of varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis (strength, route of administration, anatomical injection site and frequency were not reported); lot number W002599 has been verified to be a valid lot number with expiration date on 24-JAN-2024 that underwent a temperature excursion of 4 Celsius degrees for 108 hours (product storage error). There was no previous temperature excursion. No additional adverse events were reported.
I had a sinus infection before I took the Pfizer (Covid vaccine) and this is reoccurring; I had a sinus infection before I took the Pfizer (Covid vaccine) and this is reoccurring; fatigue; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a 71-Year-old (same age at vaccination) female received first dose of bnt162b2 (BNT162B2, Solution for injection, Lot: ENG202) via unspecified route of administration on 27Feb2021 as single dose in left arm for COVID-19 immunization/ Because I am over 55 years old. Medical history reported was ongoing asthma, ongoing high blood pressure, ongoing cholesterol, hay fever and ongoing sinus infection. Concomitant medications reported was losartan for blood pressure high, atorvastatin for cholesterol, hydrochlorothiazide it's a water pills, salbutamol (ALBUTEROL) for asthma as needed (it's a Advair DISKUS 250/50), fluticasone propionate and salmeterol xinafoate (ADVAIR). When probed for the concern, consumer stated, she had called to find out, she had taken her first dose already (27Feb2021) and her second Pfizer dose was due today this evening and she was going to get it, but she never had this sinus infection and she have been taking Amoxiclav (treatment) and she wanted to know if there was any adverse reaction to the vaccine. Onset of events was reported as a week and a half ago, it probably may be around 7 days ago. Patient had a sinus infection before she took the Pfizer (Covid vaccine) and this was reoccurring. She had Hay fever (history). Patient was due on the 2nd shot today 20Mar2021, asking for the time. But she can get her 2nd dose today. Another concern, the patient already took amoxicillin for her sinus infection after taking the 1st shot. Had this infection before taking also the 1st shot. Also, she experienced fatigue for 3 days after taking 1st shot of the vaccine. Outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 29-MAY-2013, the patient was vaccinated with a dose of VAQTA, (lot # 0100AE, expiry date OCT-2014), with the same lot of improperly stored VAQTA. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Information has been received from a physician concerning a 5 year old female with no known medical history or allergies who on 04-AUG-2000 was vaccinated SC in the right leg with a first dose of Varivax (lot # 635453/0756K). Concomitant vaccination the same day included a first dose of MMR II (lot # 633097/0255K) given SC in the left leg. There was no illness at the time of vaccination. Subsequently on 17-JAN-2006 the patient developed chicken pox. The patient presented with lesions that were too numerous to count. Follow-up information indicated that the patient had no fever, papules were noted on the trunk and hairline and itching was noted. The patient was seen for a doctor's visit. Treatment included Benadryl elixir and Aveeno bath powder 2-3 times a day. "Isolate" was noted. Subsequently, the patient recovered. There was no product quality complaint involved. It was reported that the patient had no adverse events following prior vaccination. No further information is available.
Information has been received from a female patient who was vaccinated with a dose of Gardasil. She developed arm pain which radiated from the elbow to the 4th or 5th finger. She also experienced "pins and needles" in the fingers. The patient's outcome was unknown. No further information is available.
Patient developed nausea and dry heaving along with increased blood pressure following 1st COVID vaccine administration
Headache, chills, fever, injection site hurt - from 12/21 11pm to 12/22 9:00pm acid reflux - 12/22 10 PM to 12/22 12PM
Very ill; Only able to sleep for 3 hours; Diarrhea through the night; Nausea; Chills; Headache at the back of her head (the headache was all night); Fever of 103.4; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very ill), INSOMNIA (Only able to sleep for 3 hours), DIARRHOEA (Diarrhea through the night), NAUSEA (Nausea) and CHILLS (Chills) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021 at 2:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Feb-2021, the patient experienced ILLNESS (Very ill). 17-Feb-2021, the patient experienced INSOMNIA (Only able to sleep for 3 hours), DIARRHOEA (Diarrhea through the night), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache at the back of her head (the headache was all night)) and PYREXIA (Fever of 103.4). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 21-Feb-2021, ILLNESS (Very ill), INSOMNIA (Only able to sleep for 3 hours), DIARRHOEA (Diarrhea through the night), NAUSEA (Nausea), CHILLS (Chills), HEADACHE (Headache at the back of her head (the headache was all night)) and PYREXIA (Fever of 103.4) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 103.4 (High) fever of 103.4..         No concomitants medication were reported.  Patient started to felt good on the third day.   This case was linked to MOD-2021-371308 (Patient Link).
Patient laid down after vaccines as she was experiencing dizziness. Given water. Patient stayed laying down for 5 minutes, sat up for 5 minutes and then walked to leave the clinic; however, upon leaving the exam room patient complaining of more dizziness and vomited large amount of clear fluid. Patient placed in supine position and dizziness subsided. BP 102/60  P- 80  No respiratory distress.   Patient remained for an additional 15 minutes, and then left alert and oriented x3 and walked out on her own.  Patient monitored by RNP, RN and MA throughout course of this incident.
Patient asked for Spikevax, however was billed and administered for the fluarix.
This case was reported by a consumer via call center representative and described the occurrence of depression in a adult female patient who received SHINGRIX for prophylaxis. On 21st September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 mg. In September 2018, less than a week after receiving SHINGRIX, the patient experienced depression, crying, decreased immune responsiveness and tiredness. On an unknown date, the outcome of the depression, crying, decreased immune responsiveness and tiredness were not recovered/not resolved. It was unknown if the reporter considered the depression, crying, decreased immune responsiveness and tiredness to be related to SHINGRIX. Additional details were provided as follows: The caller reported side affects from her 1st vaccine of SHINGRIX on 21st september 2018 (Friday), She reported she had depression, was crying constantly, tired, and her immune system was decreased. She reported she would not get the 2nd vaccine of SHINGRIX. No PQC, unable to obtain the physician's name and phone number secondary to call flow. The patient was angry because of side affects, would not get 2nd vaccine.
Patient came in stating that arm was severely hurting (couldn't lift or move). I explained to use warm compresses/TYLENOL/keep moving and that this was common with PREVNAR. Also called Doctor, which she went to see. They instructed her the same course of treatment according to patient. Still not satisfied with treatment, still hurts.
Pins and needles, vibration feeling in body especially arms, neuropathy , dizziness
Received vaccine and within 5 mins complained of chest pain, tightness, SOB, throat tightness, tongue swelling and dry mouth. Gave .5ml epinephrine in (L) arm and called squad who transported her to ER.
Hive like swelling just about an inch away from the injection site. Itchy and sensitive/sore. Still persists 10 days later but starting to look bruised with a red ring around the lump. Approx 2-3 in in diameter
This case was reported by a other health professional via sales rep and described the occurrence of adverse reaction in a female patient who received Seasonal Influenza vaccine. On an unknown date, the patient received Seasonal Influenza vaccine at an unknown dose. On an unknown date, an unknown time after receiving Seasonal Influenza vaccine, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to Seasonal Influenza vaccine. Additional details were provided as follows: The age at vaccination was not provided. The details of the reaction was not reported. For tolerability after FLUARIX QUADRIVALENT, please see case US2016GSK166609.
The right shoulder was hurting within an hour of the shot. The pain got steadily worse. An urgent care doctor said it would go away and I should get the second dose. She recommended massage and or chiropractor care since the muscles seemed very tense. I received the second dose and tried both massage and chiropractic manipulation. Dr. eventually decided to stop the chiropractic manipulation because the pain was increasing and she believed she was on the verge of additional harm. She referred me to Dr. office. At the time of the appointment with the orthopaedist?s office, I could barely move my arm without pain and it was numb. I could barely grip a pen and my husband had to fill out the forms.   A cortisone shot was given, a nerve study was performed, and I have had physical therapy.  Six months later I have functional mobility in my right arm, but it is still painful at times, and I do not have my full range of motion.
April 01 2021 09:00 Am, Severe Chills with 102.8 Fever lasted until 10:00PM. April 02 2021 11:00 AM Wide Spread Muscle Pain continuing April 03 2021 06:00AM April 03 2021 06:00AM Continuing Wide Muscle Pain with Nausea starting 04:30AM
Patient is here to receive his first COVID-19 vaccine. He was inadvertently given the vaccine with a filtered needle, BD 305211, Blunt needle- filter, 5 Micron, 18g x 1 1/2 inch. Vaccine has white particles with size of particles not available.
7-10 days p/vax pt felt numbness in toes & fingers;p/3wk much stiffness & muscles aching;hosp on 19JUN97 much testing-spinal tap & neuro testing;dx GBS;remains hosp for therapy & rehab;
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's physician recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 31-MAY-2013, a physician administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 02-NOV-2016, the patient was treated by the physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.